News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alquest Inc. Support Yields Vital BLA Clearance For Olympus America



10/19/2005 5:09:07 PM

MINNEAPOLIS--(BUSINESS WIRE)--Aug. 11, 2005--Alquest - the leading contract research organization (CRO) specializing in medical devices and biologics -- recently helped its client, Olympus America, earn a vital clearance for a BLA (biologics license application). After providing program management and development support, Alquest was gratified to learn that the BLA was cleared by the U.S. Food and Drug Administration (FDA) without a single data point questioned or challenged.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES